Evaluation of Autophagy as a possible therapeutic target in the Muscular Dystrophy of Emery-Dreifuss type 1 (EDMD1)

Objective: To determine if autophagy is altered in cells by EDMD1 patients and if treatment with rapamycin is able to reactivate the possible blockage of the autophagy flow in these cells.

RESEARCHERS: Cristina Capanni (Coordinator) CNR Researcher - Giovanna Lattanzi First CNR Researcher - Vittoria Cenni CNR Researcher - Camilla Evangelisti CNR Researcher - Elisabetta Mattioli CNR Researcher - Stefano Squarzoni CNR First Researcher

Status: in progress